Performance of baseline FDG-PET/CT radiomics for prediction of bone marrow minimal residual disease status in the LyMa-101 trial

Performance of baseline FDG-PET/CT radiomics for prediction of bone marrow minimal residual disease status in the LyMa-101 trial

Abstract The prognostic value of 18F-Fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) at baseline or the predictive value of minimal residual disease (MRD) detection appear as potential tools to improve mantle cell lymphoma (MCL) patients’ management. The LyMa-101, a...

Full description

Bibliographic Details
Main Authors: Caroline Bodet-Milin, Cyrille Morvant, Thomas Carlier, Gauthier Frecon, Olivier Tournilhac, Violaine Safar, Françoise Kraeber-Bodere, Steven Le Gouill, Elizabeth Macintyre, Clément Bailly
Format: Article
Language:English
Published: Nature Portfolio 2023-10-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-45215-y

Internet

https://doi.org/10.1038/s41598-023-45215-y

Similar Items